|
5 Companies |
|
3 Products |
|
3 Products |
|
4 Mechanisms of Action |
|
0 Trials |
|
45 News |
|
- | NN1213 / Novo Nordisk
Trial completion: An Investigation Into the Effect of Liquorice Ingestion on the Salivary Cortisol to Cortisone Molar Ratio (clinicaltrials.gov) - Apr 11, 2019
P=N/A, N=12, Completed, Sponsor: The Royal Wolverhampton Hospitals NHS Trust
Recruiting --> Completed
- | Trial completion, Trial completion date: 11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism (clinicaltrials.gov) - Mar 11, 2019
P=N/A, N=40, Completed, Sponsor: Helsinki University Central Hospital
Recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Dec 2022 --> Mar 2019
- | Trial completion: PHA-FMD: Primary Hyperaldosteronism and Ischemia-reperfusion Injury (clinicaltrials.gov) - Oct 12, 2017
P=N/A, N=40, Completed, Sponsor: Radboud University
Active, not recruiting --> Completed | Trial completion date: Dec 2022 --> Mar 2019 Enrolling by invitation --> Completed
- | Trial completion, Trial primary completion date: Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy (clinicaltrials.gov) - Oct 6, 2017
P=N/A, N=83, Completed, Sponsor: Seoul National University Hospital
Enrolling by invitation --> Completed Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Feb 2016
- | Minnebro (esaxerenone) / Daiichi Sankyo
Trial completion: Study of CS-3150 in Patients With Primary Aldosteronism (clinicaltrials.gov) - Aug 14, 2017
P=N/A, N=44, Completed, Sponsor: Daiichi Sankyo Co., Ltd.
Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Feb 2016 Active, not recruiting --> Completed
- | Enrollment open, Trial primary completion date: An Investigation Into the Effect of Liquorice Ingestion on the Salivary Cortisol to Cortisone Molar Ratio (clinicaltrials.gov) - Jul 21, 2017
P=N/A, N=12, Recruiting, Sponsor: The Royal Wolverhampton Hospitals NHS Trust
Active, not recruiting --> Completed Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2017 --> Oct 2017
- Minnebro (esaxerenone) / Daiichi Sankyo
Enrollment closed, Phase classification: Study of CS-3150 in Patients With Primary Aldosteronism (clinicaltrials.gov) - May 16, 2017
P=N/A, N=40, Active, not recruiting, Sponsor: Daiichi Sankyo Co., Ltd.
Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2017 --> Oct 2017 Recruiting --> Active, not recruiting | Phase classification: P3 --> PN/A
- | Trial primary completion date: PHA-FMD: Primary Hyperaldosteronism and Ischemia-reperfusion Injury (clinicaltrials.gov) - Apr 18, 2017
P=N/A, N=40, Enrolling by invitation, Sponsor: Radboud University
Recruiting --> Active, not recruiting | Phase classification: P3 --> PN/A Trial primary completion date: Jul 2016 --> May 2017
- Trial completion, Enrollment change: ODPA: Optimizing Diagnosis Of Primary Aldosteronism (clinicaltrials.gov) - Nov 14, 2016
P=N/A, N=300, Completed, Sponsor: Chongqing Medical University
Trial primary completion date: Jul 2016 --> May 2017 Recruiting --> Completed | N=180 --> 300
- New trial: An Investigation Into the Effect of Liquorice Ingestion on the Salivary Cortisol to Cortisone Molar Ratio (clinicaltrials.gov) - Oct 18, 2016
P=N/A, N=12, Not yet recruiting, Sponsor: The Royal Wolverhampton Hospitals NHS Trust
- | Minnebro (esaxerenone) / Daiichi Sankyo
Enrollment open: Study of CS-3150 in Patients With Primary Aldosteronism (clinicaltrials.gov) - Oct 11, 2016
P3, N=40, Recruiting, Sponsor: Daiichi Sankyo Co., Ltd.
Recruiting --> Completed | N=180 --> 300 Not yet recruiting --> Recruiting
- Enrollment closed, Trial primary completion date: Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy (clinicaltrials.gov) - Sep 19, 2016
P=N/A, N=84, Active, not recruiting, Sponsor: Seoul National University Hospital
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2017 --> Sep 2016
- ||| Minnebro (esaxerenone) / Daiichi Sankyo
New P3 trial: Study of CS-3150 in Patients With Primary Aldosteronism (clinicaltrials.gov) - Aug 30, 2016
P3, N=40, Not yet recruiting, Sponsor: Daiichi Sankyo Co., Ltd.
- Trial primary completion date: ODPA: Optimizing Diagnosis Of Primary Aldosteronism (clinicaltrials.gov) - Jul 27, 2016
P=N/A, N=180, Recruiting, Sponsor: Chongqing Medical University
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2017 --> Sep 2016 Trial primary completion date: May 2016 --> Dec 2016
- New trial: ODPA: Optimizing Diagnosis Of Primary Aldosteronism (clinicaltrials.gov) - May 2, 2016
P=N/A, N=180, Recruiting, Sponsor: Chongqing Medical University
- Trial completion, Enrollment change, Trial primary completion date: PAGODE: Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment (clinicaltrials.gov) - Apr 7, 2016
P=N/A, N=700, Completed, Sponsor: Radboud University
Trial primary completion date: May 2016 --> Dec 2016 Not yet recruiting --> Completed | N=1100 --> 700 | Trial primary completion date: Sep 2015 --> Dec 2015
- Clinical protocol, Trial completion: Natural History of Apparent Mineralocorticoid Excess Syndrome (clinicaltrials.gov) - Dec 12, 2015
P=N/A, N=130, Completed, Sponsor: Icahn School of Medicine at Mount Sinai
Not yet recruiting --> Completed | N=1100 --> 700 | Trial primary completion date: Sep 2015 --> Dec 2015 Recruiting --> Completed
- Trial completion: The Effect of Disease-specific Treatment on Bone Turnover Markers in Patients With Primary Aldosteronism (clinicaltrials.gov) - Dec 4, 2015
P=N/A, N=35, Completed, Sponsor: University Malaysia Sarawak
Recruiting --> Completed Recruiting --> Completed
- Enrollment change, Trial withdrawal: Microvascular Function in Primary Aldosteronism (clinicaltrials.gov) - Aug 25, 2015
P=N/A, N=0, Withdrawn, Sponsor: Maastricht University Medical Center
Recruiting --> Completed N=40 --> 0 | Recruiting --> Withdrawn
- Trial completion: Arterial Stiffness Index as a Predictor of Surgically Correctable Primary Aldosteronism (clinicaltrials.gov) - Aug 19, 2015
P=N/A, N=96, Completed, Sponsor: University Hospital, Toulouse
N=40 --> 0 | Recruiting --> Withdrawn Active, not recruiting --> Completed
- Enrollment closed, Trial primary completion date: 11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism (clinicaltrials.gov) - Aug 19, 2015
P=N/A, N=40, Active, not recruiting, Sponsor: Helsinki University Central Hospital
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Aug 2015
- | Trial completion, Trial primary completion date, HEOR, Cost effectiveness: SPARTACUS: Subtyping Primary Aldosteronism: a Randomized Trial Comparing Adrenal Vein Sampling and Computed Tomography Scan. (clinicaltrials.gov) - Jul 16, 2015
P3, N=200, Completed, Sponsor: Radboud University
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Aug 2015 Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Jul 2015
- Trial primary completion date: PHA-FMD: Primary Hyperaldosteronism and Ischemia-reperfusion Injury (clinicaltrials.gov) - Jun 24, 2015
P=N/A, N=40, Enrolling by invitation, Sponsor: Radboud University
Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Jul 2015 Trial primary completion date: Nov 2014 --> Jul 2016
- Enrollment change: The Role of Mineralocorticoid Receptors in Vascular Function (clinicaltrials.gov) - May 28, 2015
P2/3, N=15, Completed, Sponsor: Brigham and Women's Hospital
Trial primary completion date: Nov 2014 --> Jul 2016 N=20 --> 15
- Enrollment open, Trial initiation date: Microvascular Function in Primary Aldosteronism (clinicaltrials.gov) - Mar 11, 2015
P=N/A, N=40, Recruiting, Sponsor: Maastricht University Medical Center
N=20 --> 15 Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Sep 2014
- Enrollment closed: Arterial Stiffness Index as a Predictor of Surgically Correctable Primary Aldosteronism (clinicaltrials.gov) - Mar 11, 2015
P=N/A, N=110, Active, not recruiting, Sponsor: University Hospital, Toulouse
Not yet recruiting --> Recruiting | Initiation date: May 2014 --> Sep 2014 Recruiting --> Active, not recruiting
- losartan / Generic mfg., captopril / Generic mfg.
Trial completion: Kallikrein-kinin (KKS) and Renin-angiotensin-aldosterone System (RAAS) in Primary Aldosteronism (clinicaltrials.gov) - Dec 19, 2014
P4, N=100, Completed, Sponsor: National Taiwan University Hospital
Recruiting --> Active, not recruiting Recruiting --> Completed
- Clinical: The Effect of Disease-specific Treatment on Bone Turnover Markers in Patients With Primary Aldosteronism (clinicaltrials.gov) - Aug 15, 2014
P=N/A, N=36, Recruiting, Sponsor: University Malaysia Sarawak
- Clinical: Microvascular Function in Primary Aldosteronism (clinicaltrials.gov) - Mar 24, 2014
P=N/A, N=40, Not yet recruiting, Sponsor: Maastricht University Medical Center
- Enrollment open: PHA-FMD: Primary Hyperaldosteronism and Ischemia-reperfusion Injury (clinicaltrials.gov) - Nov 5, 2013
P=N/A, N=40, Enrolling by invitation, Sponsor: Radboud University
Recruiting --> Completed Not yet recruiting --> Enrolling by invitation
- | New P4 trial: Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy (clinicaltrials.gov) - Oct 8, 2013
P4, N=65, Completed, Sponsor: Jagiellonian University
- Trial completion: Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy (clinicaltrials.gov) - Oct 7, 2013
P4, N=65, Completed, Sponsor: Jagiellonian University
Not yet recruiting --> Enrolling by invitation Not yet recruiting --> Completed
- Enrollment change: Intraoperative Analysis of Cortisol During Adrenal Vein Sampling (clinicaltrials.gov) - Aug 27, 2013
P=N/A, N=21, Completed, Sponsor: Haukeland University Hospital
Not yet recruiting --> Completed N=28 --> 21
- Trial completion: Intraoperative Analysis of Cortisol During Adrenal Vein Sampling (clinicaltrials.gov) - Aug 27, 2013
P=N/A, N=21, Completed, Sponsor: Haukeland University Hospital
N=28 --> 21 Enrolling by invitation --> Completed
- | Enrollment closed, HEOR, Cost effectiveness: SPARTACUS: Subtyping Primary Aldosteronism: a Randomized Trial Comparing Adrenal Vein Sampling and Computed Tomography Scan. (clinicaltrials.gov) - Jul 24, 2013
P3, N=200, Active, not recruiting, Sponsor: Radboud University
Enrolling by invitation --> Completed Recruiting --> Active, not recruiting
- Trial initiation date: PAGODE: Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment (clinicaltrials.gov) - Jul 22, 2013
P=N/A, N=1100, Not yet recruiting, Sponsor: Radboud University
Recruiting --> Active, not recruiting Initiation date: Apr 2013 --> Sep 2013
- spironolactone / Generic mfg.
Clinical: Etiology of Sleep Apnea-related Hyperaldosteronism - BP Treatment (clinicaltrials.gov) - Jul 10, 2013
P=N/A, N=41, Completed, Sponsor: University of Alabama at Birmingham
- Clinical: PAGODE: Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment (clinicaltrials.gov) - Nov 15, 2012
P=N/A, N=1100, Not yet recruiting, Sponsor: Radboud University
- Enrollment open: Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy (clinicaltrials.gov) - Sep 9, 2012
P=N/A, N=84, Recruiting, Sponsor: Seoul National University Hospital
Initiation date: Apr 2013 --> Sep 2013 Not yet recruiting --> Recruiting
- Enrollment change: Adrenal Vein Sampling International Study (AVIS Study) (clinicaltrials.gov) - Dec 20, 2011
P=N/A, N=2604, Completed, Sponsor: University Hospital Padova
Not yet recruiting --> Recruiting N=1900 --> 2604
- Trial completion: Adrenal Vein Sampling International Study (AVIS Study) (clinicaltrials.gov) - Dec 20, 2011
P=N/A, N=2604, Completed, Sponsor: University Hospital Padova
N=1900 --> 2604 Active, not recruiting --> Completed
- Clinical: Prevalence of Primary Aldosteronism in Patients With Resistant Hypertension in China (clinicaltrials.gov) - Oct 20, 2011
P=N/A, N=2000, Completed, Sponsor: Shanghai Jiao Tong University School of Medicine
- Trial completion: PHACARV: Cardiovascular Evaluation of Adult PHA 1 Patients (clinicaltrials.gov) - Aug 8, 2011
P=N/A, N=98, Completed, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed Recruiting --> Completed